{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Lens culinaris", "diabetes", "dipeptidyl peptidase IV", "flavonol glycoside", "molecular docking analysis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30103438", "DateCompleted": {"Year": "2018", "Month": "11", "Day": "08"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "10"}], "Language": ["eng"], "ELocationID": ["1998", "10.3390/molecules23081998"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "23", "Issue": "8", "PubDate": {"Year": "2018", "Month": "Aug", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of <i>Lens culinaris</i>: In Vitro and <i>Molecular Docking</i> Analyses.", "Abstract": {"AbstractText": ["Dipeptidyl peptidase IV (DPP-IV), a new target for the treatment of type 2 diabetes mellitus, degrades incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide. DPP-IV inhibitors shorten the inactivation of GLP-1, permitting the incretin to stimulate insulin release, thereby combating hyperglycemia. In our ongoing search for new DPP-IV inhibitors from medicinal plants and foods, three flavonol glycosides (<b>1</b>\u207b<b>3</b>) were isolated from the seeds of <i>Lens culinaris</i> Medikus (Fabaceae) and tested for their DPP-IV\u207binhibitory activity. We demonstrated for the first time, that compounds <b>1</b>\u207b<b>3</b> inhibited DPP-IV activity in a concentration-dependent manner in our in vitro bioassay system. In addition, molecular docking experiments of compounds <b>1</b>\u207b<b>3</b> within the binding pocket of DPP-IV were conducted. All investigated compounds readily fit within the active sites of DPP-IV, in low-energy conformations characterized by the flavone core structure having optimal electrostatic attractive interactions with the catalytic triad residues of DPP-IV."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do 56212, Korea. boram1606@kaeri.re.kr."}], "LastName": "Kim", "ForeName": "Bo-Ram", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do 56212, Korea. khy5012@kaeri.re.kr."}], "LastName": "Kim", "ForeName": "Hyo Young", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut Pasteur Korea, Seongnam-si, Gyeonggi-do 13488, Korea. inhee.choi@ip-korea.org."}], "LastName": "Choi", "ForeName": "Inhee", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do 56212, Korea. jbkim74@kaeri.re.kr."}], "LastName": "Kim", "ForeName": "Jin-Baek", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do 56212, Korea. chjin@kaeri.re.kr."}], "LastName": "Jin", "ForeName": "Chang Hyun", "Initials": "CH"}, {"Identifier": ["0000-0001-7824-4441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do 56212, Korea. arhan@kaeri.re.kr."}], "LastName": "Han", "ForeName": "Ah-Reum", "Initials": "AR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dipeptidyl-Peptidase IV Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonols"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "EC 3.4.14.5", "NameOfSubstance": "Dipeptidyl Peptidase 4"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Dipeptidyl Peptidase 4"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Dipeptidyl-Peptidase IV Inhibitors"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavonols"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Lens Plant"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Taylor S.I. Deconstructing type 2 diabetes. Cell. 1999;97:9\u201312. doi: 10.1016/S0092-8674(00)80709-6.", "ArticleIdList": ["10.1016/S0092-8674(00)80709-6", "10199397"]}, {"Citation": "Nauck M. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes Obes. Metab. 2016;18:203\u2013216. doi: 10.1111/dom.12591.", "ArticleIdList": ["10.1111/dom.12591", "PMC4785614", "26489970"]}, {"Citation": "World Health Organization  Diabetes Mellitus Fact Sheet.  [(accessed on 23 July 2018)]; Available online:  http://www.who.int/news-room/fact-sheets/detail/diabetes."}, {"Citation": "Rasmussen H.B., Branner S., Wiberg F.C., Wagtmann N. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 2003;10:19\u201325. doi: 10.1038/nsb882.", "ArticleIdList": ["10.1038/nsb882", "12483204"]}, {"Citation": "Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul. Pept. 1999;85:9\u201324. doi: 10.1016/S0167-0115(99)00089-0.", "ArticleIdList": ["10.1016/S0167-0115(99)00089-0", "10588446"]}, {"Citation": "Langley A.K., Suffoletta T.J., Jennings H.R. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 Diabets Mellitus. Pharmacotheraphy. 2007;27:1163\u20131180. doi: 10.1592/phco.27.8.1163.", "ArticleIdList": ["10.1592/phco.27.8.1163", "17655515"]}, {"Citation": "Vilsboll T., Krarup T., Madsbad S., Holst J.J. No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose. Diabetic Med. 2001;18:144\u2013149. doi: 10.1046/j.1464-5491.2001.00424.x.", "ArticleIdList": ["10.1046/j.1464-5491.2001.00424.x", "11251679"]}, {"Citation": "Kerru N., Singh-Pillay A., Awolade P., Singh P. Current anti-diabetic agents and their molecular targets: A review. Eur. J. Med. Chem. 2018;152:436\u2013488. doi: 10.1016/j.ejmech.2018.04.061.", "ArticleIdList": ["10.1016/j.ejmech.2018.04.061", "29751237"]}, {"Citation": "Zhang B., Deng Z., Tang Y., Chen P., Liu R., Ramdath D.D., Liu Q., Hernandez M., Tsao R. Fatty acid, carotenoid and tocopherol compositions of 20 Canadian lentil cultivars and synergistic contribution to antioxidant activities. Food Chem. 2014;161:296\u2013304. doi: 10.1016/j.foodchem.2014.04.014.", "ArticleIdList": ["10.1016/j.foodchem.2014.04.014", "24837953"]}, {"Citation": "Zhang B., Deng Z., Ramdath D.D., Tang Y., Chen P.X., Liu R., Liu Q., Tsao R. Phenolic profiles of 20 Canadian lentil cultivars and their contribution to antioxidant activity and inhibitory effects on a-glucosidase and pancreatic lipase. Food Chem. 2015;172:862\u2013872. doi: 10.1016/j.foodchem.2014.09.144.", "ArticleIdList": ["10.1016/j.foodchem.2014.09.144", "25442631"]}, {"Citation": "Boudjou S., Oomah B.D., Zaidi F., Hosseinian F. Phenolics content and antioxidant and anti-inflammatory activities of legume fractions. Food Chem. 2013;138:1543\u20131550. doi: 10.1016/j.foodchem.2012.11.108.", "ArticleIdList": ["10.1016/j.foodchem.2012.11.108", "23411279"]}, {"Citation": "Chan Y.S., Yu H., Xia L., Ng T.B. Lectin from green speckled lentil seeds (Lens culinaris) triggered apoptosis in nasopharyngeal carcinoma cell lines. Chin. Med. 2015;10:25. doi: 10.1186/s13020-015-0057-6.", "ArticleIdList": ["10.1186/s13020-015-0057-6", "PMC4563850", "26357525"]}, {"Citation": "Jameel M., Ali A., Ali M. Isolation of antioxidant phytoconstituents from the seeds of Lens culinaris Medik. Food Chem. 2015;175:358\u2013365. doi: 10.1016/j.foodchem.2014.11.130.", "ArticleIdList": ["10.1016/j.foodchem.2014.11.130", "25577092"]}, {"Citation": "Tsopmo A., Muir A.D. Chemical profiling of lentil (Lens culinaris Medik.) cultivars and isolation of compounds. J. Agric. Food Chem. 2010;58:8715\u20138721. doi: 10.1021/jf101412y.", "ArticleIdList": ["10.1021/jf101412y", "20617853"]}, {"Citation": "Sagratini G., Zuo Y., Caprioli G., Cristalli G., Giardin\u00e0 D., Maggi F., Molin L., Ricciutelli M., Traldi P., Vittori S. Quantification of soyasaponins I and \u03b2g in Italian lentil seeds by solid-phase extraction (SPE) and high-performance liquid chromatography-mass spectrometry (HPLC-MS) J. Agric. Food Chem. 2009;57:11226\u201311233. doi: 10.1021/jf901707z.", "ArticleIdList": ["10.1021/jf901707z", "19950999"]}, {"Citation": "Kite G.C., Veitch N.C., Boalch M.E., Lewis G.P., Leon C.J., Simmonds M.S. Flavonol tetraglycosides from fruits of Styphnolobium. japonicum (Leguminosae) and the authentication of Fructus Sophorae and Flos Sophorae. Phytochemistry. 2009;70:785\u2013794. doi: 10.1016/j.phytochem.2009.04.003.", "ArticleIdList": ["10.1016/j.phytochem.2009.04.003", "19447452"]}, {"Citation": "Liu Q., Liu M., Mabry T.J., Dixon R.A. Flavonol glycosides from Cephalocereus. senilis. Phytochemistry. 1994;36:229\u2013231.", "ArticleIdList": ["7764840"]}, {"Citation": "Srivastava S., Shree P., Tripathi Y.B. Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: In silico and experimental approach. J. Diabetes Metab. Disord. 2017;16:46. doi: 10.1186/s40200-017-0328-0.", "ArticleIdList": ["10.1186/s40200-017-0328-0", "PMC5697100", "29201861"]}, {"Citation": "Fan J., Johnson M.H., Lila M.A., Yousef G., Mejia E.G. Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: Implications in diabetes management. Evid. Based Complement. Alternat. Med. 2013:479505. doi: 10.1155/2013/479505.", "ArticleIdList": ["10.1155/2013/479505", "PMC3773436", "24069048"]}, {"Citation": "Gao Y., Zhang Y., Zhu J., Li B., Li Z., Zhu W., Shi J., Jia Q., Li Y. Recent progress in natural products as DPP-4 inhibitors. Future Med. Chem. 2015;7:1079\u20131089. doi: 10.4155/fmc.15.49.", "ArticleIdList": ["10.4155/fmc.15.49", "26062402"]}, {"Citation": "Kalhotra P., Chittepu V.C.S.R., Osorio-Revilla G., Gallardo-Vel\u00e1zquez T. Structure-activity relationship and molecular docking od natural product library reveal chrysin as a novel dipeptidyl peptidase-4 (DPP-4) inhibitors: An integrated in silico and in vitro study. Molecules. 2018;23:1368. doi: 10.3390/molecules23061368.", "ArticleIdList": ["10.3390/molecules23061368", "PMC6100528", "29882783"]}, {"Citation": "Zhan L. Ph.D. Thesis. Jilin University; Changchun, China: 2013. Identification of Isoquercitrin as an Inhibitor of DPP-IV: Implication for Insulin Secretion and Hyperglycemic in Type 2 Diabetes Mice."}, {"Citation": "Parmar H.S., Jain P., Chauhan D.S., Bhinchar M.K., Munjal V., Yusuf M., Choube K., Tawani A., Tiwani V., Manivannan E., et al. DPP-IV inhibitory potential of narningin: An in silico, in vitro, in vivo study. Diabetes Res. Clin. Pract. 2012;97:105\u2013111. doi: 10.1016/j.diabres.2012.02.011.", "ArticleIdList": ["10.1016/j.diabres.2012.02.011", "22410395"]}, {"Citation": "Kim D., Wang L., Beconi M., Eiermann G.J., Fisher M.H., He H., Hickey G.J., Kowalchick J.E., Leiting B., Lyons K., et al. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J. Med. Chem. 2005;48:141\u2013151. doi: 10.1021/jm0493156.", "ArticleIdList": ["10.1021/jm0493156", "15634008"]}, {"Citation": "Tanwar O., Tanwar L., Shaquiquzzaman M., Alam M.M., Akhter M. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors. Bioorg. Med. Chem. Lett. 2014;24:3447\u20133451. doi: 10.1016/j.bmcl.2014.05.076.", "ArticleIdList": ["10.1016/j.bmcl.2014.05.076", "24948564"]}, {"Citation": "Schr\u00f6dinger Release 2017\u20131. Glide, Schr\u00f6dinger, LLC; New York, NY, USA: 2017."}]}], "History": [{"Year": "2018", "Month": "7", "Day": "23"}, {"Year": "2018", "Month": "8", "Day": "8"}, {"Year": "2018", "Month": "8", "Day": "8"}, {"Year": "2018", "Month": "8", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["30103438", "PMC6222902", "10.3390/molecules23081998", "molecules23081998"]}}]}